Steven F. Bellon Foghorn Therapeutics Inc. (FHTX) insider trading activity

FHTX Quotes by TradingView

Steven F. Bellon is Chief Scientific Officer of Foghorn Therapeutics Inc.. Currently has a direct ownership of 101,957 shares of FHTX, which is worth approximately $801,382. The most recent transaction as insider was on Sep 09, 2024, when has been sold 20,000 shares (Common Stock) at a price of $9.5 per share, resulting in proceeds of $190,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102K
16.4% 3M change
16.4% 12M change
Total Value Held $801,382

Steven F. Bellon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 09 2024
SELL
Open market or private sale
$190,000 $9.5 p/Share
20,000 Reduced 16.4%
101,957 Common Stock
Aug 11 2022
BUY
Exercise of conversion of derivative security
$6,912 $3.72 p/Share
1,858 Added 1.5%
121,957 Common Stock
May 25 2022
BUY
Exercise of conversion of derivative security
$9,794 $2.23 p/Share
4,392 Added 3.53%
120,099 Common Stock
SFB

Steven F. Bellon

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on FHTX

Follow Foghorn Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FHTX shares.

Notify only if

Insider Trading

Get notified when an Foghorn Therapeutics Inc. insider buys or sells FHTX shares.

Notify only if

News

Receive news related to Foghorn Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FHTX